Search results
Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 2 days agoThis includes out-of-hospital software platforms designed to support professionals and caregivers...
Sarepta Therapeutics (NASDAQ:SRPT) PT Raised to $179.00
ETF DAILY NEWS· 6 days agoSarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price hoisted by Mizuho from $145.00 to $179.00 in a report issued on Friday, Benzinga reports. The firm presently has a “ ...
Chardan Capital Weighs in on Ocugen, Inc.’s FY2024 Earnings (NASDAQ:OCGN)
ETF DAILY NEWS· 5 days agoOcugen, Inc. (NASDAQ:OCGN – Free Report) – Chardan Capital boosted their FY2024 earnings per share (EPS) estimates for Ocugen in a research note issued on Wednesday, May 15th ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoLife Science Equipment Market to be Worth $97.96 Billion by 2031 - Exclusive Report by Meticulous Research® PR Newswire REDDING, Calif., May 20, 2024 REDDING, Calif., May 20, 2024 /PRNewswire/ -- According to a new market research report titled,
Quantitative imaging reveals collagen changes in melanoma tumors during immunotherapy
Medical Xpress· 1 day agoCollagen, a major component of the extracellular matrix, plays a crucial role in tumor development. During the development of tumors ("tumorigenesis"), collagen fibers become linearized and ...
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO)
ETF DAILY NEWS· 6 days agoStockNews.com initiated coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note published on Saturday morning. The firm issued a hold rating on the ...
Celcuity (NASDAQ:CELC) Rating Reiterated by Craig Hallum
ETF DAILY NEWS· 6 days agoCraig Hallum reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a research note released on Thursday morning, Marketbeat reports. The brokerage ...
Needham & Company LLC Reaffirms Buy Rating for Autolus Therapeutics (NASDAQ:AUTL)
ETF DAILY NEWS· 5 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research note released on Friday, Benzinga reports. They ...
StockNews.com Initiates Coverage on Pulmatrix (NASDAQ:PULM)
ETF DAILY NEWS· 5 days agoEquities research analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Get Free Report) in a note issued to investors on Saturday. The brokerage ...
Dynatronics (NASDAQ:DYNT) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com assumed coverage on shares of Dynatronics (NASDAQ:DYNT – Free Report) in a research note published on Saturday morning. The firm issued a hold rating on the ...